Downloads provided by UsageCounts
These data supplement the article A randomised controlled trial of Losartan as an antifibrotic agent in non-alcoholic steatohepatitis. Stuart McPherson, Nina Wilkinson, Dina Tiniakos, Jennifer Wilkinson, Alastair Burt, Elaine McColl, Deborah D. Stocken, Nick Steen, Jane Barnes, Nicola Goudie, Stephen Stewart, Yvonne Bury5, Derek Mann, Quentin M. Anstee, Christopher P. Day. Use is free for academic purposes, provided the aforementioned article is appropriately cited. The data consists of anonymised csv data files, described in DataDictionaryFELINE.csv, the final protocol and a blank copy of the case report forms used (both pdf).
non-alcoholic statohepatitis, diabetes, treatment, losartan, non-alcoholic fatty liver disease, angiotensin converting enzyme inhibitor, liver fibrosis, angiotensin recptor blocker
non-alcoholic statohepatitis, diabetes, treatment, losartan, non-alcoholic fatty liver disease, angiotensin converting enzyme inhibitor, liver fibrosis, angiotensin recptor blocker
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 6 | |
| downloads | 7 |

Views provided by UsageCounts
Downloads provided by UsageCounts